Overview
This volume is the first text to concisely yet comprehensively cover developments for both alcoholic and nonalcoholic fatty liver disease in an organized fashion. Aspects of these two diseases covered in the book include global epidemiology and risk factors, pathogenesis, animal models, hepatic and extra-hepatic malignancies, treatment models, and current and emerging therapies. Written by experts in the field, Alcoholic and Non-Alcoholic Fatty Liver Disease: Bench to Bedside is a valuable resource for gastroenterologists, pathologists, and hepatologists who treat patients with alcoholic and nonalcoholic fatty liver disease.
Full Product Details
Author: Naga Chalasani ,
Gyongyi Szabo
Publisher: Springer International Publishing AG
Imprint: Springer International Publishing AG
Edition: Softcover reprint of the original 1st ed. 2016
Weight: 0.998kg
ISBN: 9783319793085
ISBN 10: 331979308
Pages: 372
Publication Date: 27 March 2019
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Paperback
Publisher's Status: Active
Availability: Manufactured on demand
We will order this item for you from a manufactured on demand supplier.
Reviews
“The purpose is to serve as a review of both mechanisms of liver disease. The book is meant to compare the two unique diseases, which share several mechanisms. … The book summarizes current knowledge and contains updates on recent research. … This is a high quality resource on the topic of alcoholic and nonalcoholic fatty liver disease, providing an in-depth discussion of the mechanisms … .” (Ryan R. Sefcik, Doody's Book Reviews, June, 2016)
The purpose is to serve as a review of both mechanisms of liver disease. The book is meant to compare the two unique diseases, which share several mechanisms. ... The book summarizes current knowledge and contains updates on recent research. ... This is a high quality resource on the topic of alcoholic and nonalcoholic fatty liver disease, providing an in-depth discussion of the mechanisms ... . (Ryan R. Sefcik, Doody's Book Reviews, June, 2016)
Author Information
Drs. Chalasani and Szabo are senior investigators in the field of fatty liver disease and have had extensive federal funding to investigate these areas. They both hold leadership positions and are recognized as experts in the field of fatty liver disease. For example, Dr. Chalasani is the lead author of the multi-society practice guideline on the diagnosis and management of nonalcoholic fatty liver disease& Dr. Szabo is the president-elect of the American Association for the Study of Liver Disease which is the largest liver society in the world. They are also actively practicing clinicians and thus aware of clinically relevant knowledge gaps in the field.
